Novozymes A/S (OTCMKTS:NVZMY) Shares Break Below Fifty Day Moving Average – Here’s What Happened

Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $67.32 and traded as low as $65.9101. Novozymes A/S shares last traded at $66.25, with a volume of 352,236 shares trading hands.

Novozymes A/S Price Performance

The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 0.25. The company’s 50 day moving average is $67.18 and its 200 day moving average is $62.72. The firm has a market capitalization of $27.67 billion, a price-to-earnings ratio of 37.75, a P/E/G ratio of 3.01 and a beta of 0.86.

Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.26). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.28 billion. Novozymes A/S had a return on equity of 6.56% and a net margin of 15.59%. On average, equities research analysts anticipate that Novozymes A/S will post 2.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Novozymes A/S

A hedge fund recently raised its position in Novozymes A/S stock. Elefante Mark B lifted its stake in Novozymes A/S (OTCMKTS:NVZMY – Free Report) by 73.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,900 shares of the biotechnology company’s stock after buying an additional 2,500 shares during the period. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent filing with the Securities and Exchange Commission. 0.03% of the stock is currently owned by hedge funds and other institutional investors.

About Novozymes A/S

(Get Free Report)

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.

Further Reading

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.